nAMD

7 registered clinical trials studyying nAMD — 6 currently recruiting.

Status	Trial	Sponsor	Phase
Enrolling By Invitation	Safety and Efficacy Study of IVB103 Injection in Subjects With Neovascular (Wet) Agerelated Macular Degenerati NCT06737354	InnoVec Biotherapeutics Inc.	Phase 1
Recruiting	Multicenter, Phase I/II Study to Evaluate the Safety, Tolerability, PK and Efficacy of SCT520FF in Patients Wi NCT06672536	Sinocelltech Ltd.	Phase 1 / Phase 2
Recruiting	A Study of the Efficacy, Safety, and Pharmacokinetics (PK) of the Port Delivery System With Ranibizumab (PDS) NCT05562947	Hoffmann-La Roche	Phase 3
Completed	Targeted Fluorescence Imaging in AMD NCT05262244	University Medical Center Groningen	Phase 1
Recruiting	Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD NCT05407636	AbbVie	Phase 3
Enrolling By Invitation	Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With nAMD NCT05210803	AbbVie	—
Recruiting	Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One NCT04704921	AbbVie	Phase 2 / Phase 3